Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 12090123 Extended release pharmaceutical formulation

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Yuefeng Long0

Peter William Surman0

Natalie June Medlicott0

Paul William Glue0

Date of Patent

September 17, 2024

0

Patent Application Number

170307050

Date Filed

September 24, 2020

0

Patent Citations

US Patent 8114383 Abuse-proofed dosage form

0

US Patent 8137711 Methods of treating neuropathy

0

US Patent 8309060 Abuse-proofed dosage form

0

US Patent 9272037 Method to treat premature ejaculation in humans

0

US Patent 9533982 Substituted bicyclic heteroaryl carboxamide analogs as mGluR5 negative allosteric modulators

0

US Patent 9650352 Use of (2R, 6R)-hydroxynorketamine, (S)-dehydronorketamine and other stereoisomeric dehydro and hydroxylated metabolites of (R,S)-ketamine in the treatment of depression and neuropathic pain

0

US Patent 9850362 Modified starch compositions, starch composite foam materials and method for preparing the starch composite foam material

0

US Patent 9867830 Use of (2R, 6R)-hydroxynorketamine, (S)-dehydronorketamine and other stereoisomeric dehydro and hydroxylated metabolites of (R,S)-ketamine in the treatment of depression and neuropathic pain

0

...

Patent Primary Examiner

0

Patent abstract

The disclosure provides a dosing regimen utilizing an oral extended release formulation for the treatment of treatment-resistant depression and treatment-resistant anxiety.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 12090123 Extended release pharmaceutical formulation

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool